Myocarditis/CMP | Suspected CAD/Ischemia | Viability | |
---|---|---|---|
All (from n = 27781) | 32.2% | 34.2% | 14.6% |
Completely new diagnosis not suspected before | 11.4% | 8.1% | 5.3% |
Therapeutic consequences | |||
Change in medication | 25.3% | 24.3% | 33.2% |
Invasive procedure | 6.9% | 23.1% | 24.2% |
Hospital discharge | 10.4% | 14.3% | 6.9% |
Hospital admission | 1.1% | 1.5% | 1.9% |
Impact on patient management (new diagnosis and/or therapeutic consequence) | 55.1% | 71.4% | 71.5% |